SCHEMBL16897945

SCHEMBL16897945

CC(C)(C)N1CC[C@H](c2ccc(OCc3ccccc3)cc2)[C@@H](O)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.51
RAB9A P51151 3/20 0.51
MAOA P21397 6/20 0.44
MAOB P27338 6/20 0.44
KDM1A O60341 5/20 0.44
S1PR5 Q9H228 1/20 0.44
TP53 P04637 3/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPK1 P28482 1/20 0.43
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
CYP2C19 P33261 1/20 0.42
PTGS2 P35354 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16897870 1.00 NPC1 (0.51) NPC1RAB9AMAOAMAOBKDM1A
SCHEMBL16874865 0.80 YAP1 (0.54) NPC1RAB9AMAOAMAOBKDM1A
SCHEMBL16874807 0.80 YAP1 (0.54) NPC1RAB9AMAOAMAOBKDM1A
SCHEMBL3071701 0.80 YAP1 (0.54) NPC1RAB9AMAOAMAOBKDM1A
SCHEMBL16874742 0.80 YAP1 (0.54) NPC1RAB9AMAOAMAOBKDM1A
SCHEMBL3069231 0.80 NPC1 (0.52) NPC1RAB9AMAOAMAOBKDM1A
SCHEMBL6625519 0.79 HRH3 (0.57) NPC1RAB9AS1PR5TP53KDM4E
SCHEMBL6625517 0.79 HRH3 (0.57) NPC1RAB9AS1PR5TP53KDM4E
SCHEMBL6959509 0.79 NPC1 (0.44) NPC1RAB9AMAOAMAOBKDM1A
SCHEMBL4601018 0.78 CHRM4 (0.54) NPC1RAB9AMAOAMAOBKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092224-A1 SELECTIVE NR2B ANTAGONISTS Bristol-Myers Squibb Company (US) 2016-11-16 EP disclosed
WO-2015105772-A1 SELECTIVE NR2B ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-07-16 WO disclosed